Abstract
Hepatic resection for metastases from colorectal cancer is the only method to obtain significant survival for patients with these tumors. Its use has become increasingly frequent over the last 20 years. There are many reasons for the increased use of hepatic resection, including new breakthroughs in earlier diagnosis of hepatic tumors, the use of more sophisticated intraoperative equipment, including intraoperative ultrasound and the ultrasonic dissector, as well as increased familiarity with hepatic anatomy and increased confidence in the ability to resect selected segments of the liver.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Starzl TE, Bell RH, Beart RW, et al. 1975. Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet 141:429.
Wilson SM, Adson MA. 1976. Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg 111:330.
Adson MA, van Heerden JA, Adson MH, et al. 1984. Resection of hepatic metastases from colorectal cancer. Arch Surg 119:647–651.
Butler J, Attiyeh FF, Daly JM. 1986. Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 162:109–113.
Roh M. 1989. Hepatic resection for colorectal liver metastases. Hematol Oncol Clin North Am 3:171–181.
Hughes KS, Scheele J, Sugarbaker PH. 1989. Surgery for colorectal cancer metastatic to the liver: Optimizing the result of treatment. Surg Clin North Am 69:339–359.
Elias D, Lasser P, Rougier P, et al. 1992. Nouvel echec dans la tentative de definition des indications d’exerese des metastases hepatiques d’origine colo-rectales. J Chirurgie (Paris).
Doci R, Gennari L, Bignami P, et al. 1991. One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants. Br J Surg 78:797–801.
Schlag P, Hohengerger P, Herfarth CH. 1990. Resection of liver metastases in colorectal cancer-competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 16:360–365.
Ensminger WD, Rosowsky A, Raso V, et al. 1978. A clinical pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2’-deoxyuridine and 5-fluorouracil. Cancer Res 38 (II Pt l):3784–3792.
Daly MJ, Kemeny N, Sigurdson E, et al. 1987. Regional infusion for colorectal hepatic metastases. Arch Surg 122:1273–1277.
Kemeny N, Daly J, Reichman B, et al. 1987. Intrahepatic or systemic infusion of fluo-rodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 107:459–465.
Hohn CD, Stagg JR, Fiedman AM, et al. 1989. A randomized trial of continuous intravenous versus hepatic intraarterial floxurindine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group Trial. J Clin Oncol 7:1646–1654.
Kemeny, MM, Goldberg D, Beatty D, et al. 1986. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 57:492–498.
Wagman DL, Kemeny MM, Leong L, et al. 1990. A prospective randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 8:1885–1893.
Patt ZY, McBride MC, Ames CF, et al. 1987. Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer 59:867–872.
Tsujitani S, Watanabe A, Kakeji Y, et al. 1991. Hepatic recurrence not prevented with low-dosage long-term intraportal 5-FU infusion after resection of colorectal liver metastasis. Eur J Surg Oncol 17:526–529.
Lise M, Da Pian P, Nitti D, et al. 1992. Colorectal metastases to the liver: Present results and future strategies. J Surg Oncol 2:69–73.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Kemeny, M.M. (1994). Chemotherapy after hepatic resection of colorectal metastases. In: Sugarbaker, P.H. (eds) Hepatobiliary Cancer. Cancer Treatment and Research, vol 69. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2604-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2604-9_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6115-2
Online ISBN: 978-1-4615-2604-9
eBook Packages: Springer Book Archive